Maven Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,840	Closed	-$1.39M	–	563
2025 Q3	$1.39M	Sell	13,840 -28,277	-67%	-$2.55M	0.03%	332
2025 Q2	$3.49M	Buy	42,117 +23,011	+120%	+$1.84M	0.08%	223
2025 Q1	$1.55M	Buy	19,106 +8,214	+75%	+$734K	0.05%	333
2024 Q4	$981K	Buy	10,892 +828	+8%	+$80.2K	0.02%	421
2024 Q3	$994K	Sell	10,064 -77,095	-88%	-$7.57M	0.02%	501
2024 Q2	$8.08M	Buy	87,159 +37,638	+76%	+$3.37M	0.18%	115
2024 Q1	$4.7M	Buy	49,521 +18,121	+58%	+$1.68M	0.28%	45
2023 Q4	$2.8M	Buy	31,400 +275	+0.9%	+$20.4K	0.06%	242
2023 Q3	$2.27M	Sell	31,125 -8,410	-21%	-$672K	0.03%	369
2023 Q2	$3.29M	Buy	+39,535	New	+$3.31M	0.05%	185
2022 Q4	–	Sell	-10,539	Closed	-$836K	–	1155
2022 Q3	$836K	Buy	+10,539	New	+$889K	0.02%	612
2022 Q2	–	Sell	-4,292	Closed	-$386K	–	1142
2022 Q1	$386K	Buy	+4,292	New	+$396K	0.01%	617
2021 Q3	–	Sell	-6,200	Closed	-$851K	–	1295
2021 Q2	$851K	Sell	6,200 -11,678	-65%	-$1.54M	0.03%	488
2021 Q1	$2.4M	Buy	17,878 +12,981	+265%	+$1.94M	0.11%	186
2020 Q4	$706K	Sell	4,897 -15,676	-76%	-$2.01M	0.07%	300
2020 Q3	$2.32M	Buy	+20,573	New	+$2.31M	0.19%	117
2018 Q4	–	Sell	-7,300	Closed	-$703K	–	175
2018 Q3	$703K	Buy	+7,300	New	+$708K	0.26%	85
2017 Q4	–	Sell	-2,500	Closed	-$215K	–	59
2017 Q3	$215K	Buy	+2,500	New	+$200K	0.11%	34
2017 Q1	–	Sell	-2,353	Closed	-$140K	–	65
2016 Q4	$140K	Buy	+2,353	New	+$145K	0.13%	29